Can HCA's gene therapy milestone drive long-term growth?
- Posted on July 1, 2026
- By Bing News
- 0 Views
- 1 min read
Can HCA's gene therapy milestone drive long-term growth?
HCA Healthcare, Inc. HCA is expanding its presence in advanced medicine after researchers from its Sarah Cannon Transplant and Cellular Therapy Program published encouraging findings in The New England Journal of Medicine. The study found that the CRISPR gene-editing therapy, exa-cel, successfully treated children aged 5 to 11 with severe sickle cell disease and transfusion-dependent beta thalassemia. It is the first published clinical study of...
